Neusoft Medical Systems Co., Ltd., a prominent player in the healthcare technology sector, is headquartered in China (CN) and operates extensively across Asia and beyond. Founded in 1998, the company has established itself as a leader in medical imaging and healthcare IT solutions, consistently innovating to enhance patient care. Neusoft Medical Systems offers a diverse range of products, including advanced CT, MRI, and ultrasound systems, distinguished by their cutting-edge technology and user-friendly design. The company’s commitment to research and development has led to significant advancements in medical diagnostics, positioning it as a trusted partner in the global healthcare market. With a strong focus on quality and innovation, Neusoft Medical Systems has achieved notable milestones, including numerous industry awards and certifications, solidifying its reputation as a key contributor to the evolution of medical technology.
How does Neusoft Medical Systems Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Neusoft Medical Systems Co., Ltd.'s score of 23 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Neusoft Medical Systems Co., Ltd., headquartered in China (CN), currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures. The company has not established any documented reduction targets or climate pledges, which suggests a lack of formal commitments to reducing greenhouse gas emissions at this time. It is important to note that Neusoft Medical Systems Co., Ltd. is a current subsidiary and may inherit emissions data or climate initiatives from its parent or related organizations. However, no specific cascading data or initiatives have been provided from the parent company or other sources. In the context of the medical technology industry, companies are increasingly expected to adopt robust climate strategies and transparency in emissions reporting. As of now, Neusoft Medical Systems Co., Ltd. has not publicly committed to any industry-standard climate initiatives such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP).
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Neusoft Medical Systems Co., Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.